论文部分内容阅读
该文对57例肝硬化病人血清sIL－2R测定，结果显示：肝硬化病人血sIL－2R较正常对照组明显增高（P＜0．05）、且与Child－Pugh分级有关；HBsAg阳性者较HBsAg阴性者升高明显（P＜0．01），合并肝癌老较未并发者升高显著（P＜0．001）。提示血清sIL－2R测定可作为肝硬化免疫失衡的重要指标；对病情和预后的判定亦有帮助。
The results of serum sIL-2R in 57 cirrhotic patients showed that serum sIL-2R in patients with cirrhosis was significantly higher than that in controls (P <0.05), and correlated with Child-Pugh classification HBsAg-negative patients increased significantly (P <0.01), and the incidence of hepatocellular carcinoma was significantly higher than those without concurrent (P <0.001). Tip serum sIL-2R determination can be used as an important indicator of liver cirrhosis immune imbalance; also determine the condition and prognosis is also helpful.